Browse the corpus

REFERENCES Bass DA, Gonwa TA, Szejda P, et al. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 1980; 65:1265. Blauwet LA, Breen JF, Edwards WD, Klarich KW. Atypical presentation of eosinophilic endomyocardial disease. Mayo Clin Proc 2005; 80:1078. Tefferi A. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc 2005; 80:75. Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010; 126:39. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006; 117:1292. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010; 126:45. Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121:203. Lombardi C, Passalacqua G. Eosinophilia and diseases: clinical revision of 1862 cases. Arch Intern Med 2003; 163:1371. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991; 324:1110. Jenerowicz D, Czarnecka-Operacz M, Silny W. Peripheral blood eosinophilia in atopic dermatitis. Acta Dermatovenerol Alp Panonica Adriat 2007; 16:47. Noh G, Jin H, Lee J, et al. Eosinophilia as a predictor of food allergy in atopic dermatitis. Allergy Asthma Proc 2010; 31:e18. Horwitz AA, Hossain J, Yousef E. Correlates of outcome for atopic dermatitis. Ann Allergy Asthma Immunol 2009; 103:146. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033. Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51:1000. Gibson PG, Hargreave FE, Girgis-Gabardo A, et al. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 1995; 25:127. Vieira VG, Prolla JC. Clinical evaluation of eosinophils in the sputum. J Clin Pathol 1979; 32:1054. Mullarkey MF. Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol 1988; 82:941. Jankowski R, Wayoff M, Faure G, et al. [Immunohistology of polyps of the nose and paranasal sinuses. Physiopathologic value]. Ann Otolaryngol Chir Cervicofac 1990; 107:243.

Vieira VG, Prolla JC. Clinical evaluation of eosinophils in the sputum. J Clin Pathol 1979; 32:1054. Mullarkey MF. Eosinophilic nonallergic rhinitis. J Allergy Clin Immunol 1988; 82:941. Jankowski R, Wayoff M, Faure G, et al. [Immunohistology of polyps of the nose and paranasal sinuses. Physiopathologic value]. Ann Otolaryngol Chir Cervicofac 1990; 107:243. Georgiou S, Maroulis J, Monastirli A, et al. Anaphylactic shock as the only clinical manifestation of hepatic hydatid disease. Int J Dermatol 2005; 44:233. Liu Z, Liu Q, Pesce J, et al. Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol Rev 2004; 201:57. Weller PF. Eosinophilia in travelers. Med Clin North Am 1992; 76:1413. Nutman TB, Ottesen EA, Ieng S, et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis 1987; 155:309. Pardo J, Carranza C, Muro A, et al. Helminth-related Eosinophilia in African immigrants, Gran Canaria. Emerg Infect Dis 2006; 12:1587. Nucci M, Portugal R, Pulcheri W, et al. Strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis 1995; 21:675. Gill GV, Bailey JW. Eosinophilia as a marker for chronic strongyloidiasis--use of a serum ELISA test to detect asymptomatic cases. Ann Trop Med Parasitol 1989; 83:249. Nutman TB. Asymptomatic peripheral blood eosinophilia redux: common parasitic infections presenting frequently in refugees and immigrants. Clin Infect Dis 2006; 42:368. Libman MD, MacLean JD, Gyorkos TW. Screening for schistosomiasis, filariasis, and strongyloidiasis among expatriates returning from the tropics. Clin Infect Dis 1993; 17:353. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 1999; 340:773. Bergner RK, Bergner A. Marked peripheral eosinophilia: a clue to allergic bronchopulmonary aspergillosis in office practice. N Engl Reg Allergy Proc 1985; 6:367. Koepke A, Albus C, Barth A, et al. [Coccidioidomycosis--differential diagnosis of lung infiltrates with peripheral eosinophilia]. Dtsch Med Wochenschr 1989; 114:218. Schermoly MJ, Hinthorn DR. Eosinophilia in coccidioidomycosis. Arch Intern Med 1988; 148:895. Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis 1994; 18:627.

Koepke A, Albus C, Barth A, et al. [Coccidioidomycosis--differential diagnosis of lung infiltrates with peripheral eosinophilia]. Dtsch Med Wochenschr 1989; 114:218. Schermoly MJ, Hinthorn DR. Eosinophilia in coccidioidomycosis. Arch Intern Med 1988; 148:895. Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis 1994; 18:627. Sanchez-Borges M, Orozco A, Di Biagio E, et al. Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993; 92:494. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996; 174:615. Friedman, H, Kaslow, R, Winkelstein, A, et al. Longitudinal changes in hematologic manifestations of HIV infection in the multicenter AIDS cohort study (MACS) (abstract). Int Conf AIDS 1991; 7:344. Marinacci, G, Brighi, S, Ricchi, E, et al. Adrenal insufficiency and acquired immunodeficiency syndrome. Int Conf AIDS 1993; 9:463. Skiest DJ, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 1997; 102:449. Paganelli R, Scala E, Mezzaroma I, et al. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995; 95:995. Drabick JJ, Magill AJ, Smith KJ, et al. Hypereosinophilic syndrome associated with HIV infection. Military Medical Consortium for Applied Retroviral Research. South Med J 1994; 87:525. May LP, Kelly J, Sanchez M. Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection. J Am Acad Dermatol 1990; 23:202. Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med 1991; 91:300. Plumelle Y, Gonin C, Edouard A, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol 1997; 107:81. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003; 54:169.

Plumelle Y, Gonin C, Edouard A, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol 1997; 107:81. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003; 54:169. Gotlib J, Cools J, Malone JM 3rd, et al. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004; 103:2879. Golkar L, Bernhard JD. Mastocytosis. Lancet 1997; 349:1379. Yam LT, Yam CF, Li CY. Eosinophilia in systemic mastocytosis. Am J Clin Pathol 1980; 73:48. Miranda RN, Esparza AR, Sambandam S, Medeiros LJ. Systemic mast cell disease presenting with peripheral blood eosinophilia. Hum Pathol 1994; 25:727. Löffler H, Gassmann W, Haferlach T. AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspects. Leuk Lymphoma 1995; 18 Suppl 1:61. Bain BJ. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996; 95:2. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989; 73:2081. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 1995; 85:1881. Navarro-Román L, Medeiros LJ, Kingma DW, et al. Malignant lymphomas of B-cell lineage with marked tissue eosinophilia. A report of five cases. Am J Surg Pathol 1994; 18:347. Enblad G, Sundstrom C, Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993; 11:187. Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75:13. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992; 16:236. Murata K, Yamada Y, Kamihira S, et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992; 69:966.

Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75:13. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992; 16:236. Murata K, Yamada Y, Kamihira S, et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992; 69:966. Samoszuk M, Ramzi E, Cooper DL. Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol 1993; 42:402. Borish L, Dishuck J, Cox L, et al. Sézary syndrome with elevated serum IgE and hypereosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 1993; 92:123. Tancrede-Bohin, E. Arch Dermatol 2004; 140:1156. Kaufman LD, Krupp LB. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 1995; 7:560. Brown JP, Rola-Pleszczynski M, Ménard HA. Eosinophilic synovitis: clinical observations on a newly recognized subset of patients with dermatographism. Arthritis Rheum 1986; 29:1147. Atanes A, Fernández V, Núñez R, et al. Idiopathic eosinophilic synovitis. Case report and review of the literature. Scand J Rheumatol 1996; 25:183. Kay J, Eichenfield AH, Athreya BH, et al. Synovial fluid eosinophilia in Lyme disease. Arthritis Rheum 1988; 31:1384. Goldenberg DL, Kelley W, Gibbons RB. Metastatic adenocarcinoma of synovium presenting as an acute arthritis. Diagnosis by closed synovial biopsy. Arthritis Rheum 1975; 18:107. Hasselbacher P, Schumacher HR. Synovial fluid eosinophilia following arthrography. J Rheumatol 1978; 5:173. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63:65. Kargili A, Bavbek N, Kaya A, et al. Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases. Rheumatol Int 2004; 24:321. Winchester RJ, Koffler D, Litwin SD, Kunkel HG. Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arthritis Rheum 1971; 14:650. BLOCH KJ, BUCHANAN WW, WOHL MJ, BUNIM JJ. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965; 44:187. Spry CJF. A Comprehensive Review and Guide to the Scientific and Medical Literature, Oxford Medical Publications, Oxford 1988.

Winchester RJ, Koffler D, Litwin SD, Kunkel HG. Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arthritis Rheum 1971; 14:650. BLOCH KJ, BUCHANAN WW, WOHL MJ, BUNIM JJ. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965; 44:187. Spry CJF. A Comprehensive Review and Guide to the Scientific and Medical Literature, Oxford Medical Publications, Oxford 1988. Falanga V, Medsger TA Jr. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol 1987; 17:648. Kaufman LD, Kephart GM, Seidman RJ, et al. The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum 1993; 36:1014. Chen KR, Su WP, Pittelkow MR, Leiferman KM. Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis. Semin Dermatol 1995; 14:106. Lie JT, Michet CJ Jr. Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries. Hum Pathol 1988; 19:598. Yousem SA, Lombard CM. The eosinophilic variant of Wegener's granulomatosis. Hum Pathol 1988; 19:682. Krupsky M, Landau Z, Lifschitz-Mercer B, Resnitzky P. Wegener's granulomatosis with peripheral eosinophilia. Atypical variant of a classic disease. Chest 1993; 104:1290. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422. Beishuizen A, Vermes I, Hylkema BS, Haanen C. Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999; 353:1675. Wilson DM, Salazer TL, Farkouh ME. Eosinophiluria in atheroembolic renal disease. Am J Med 1991; 91:186. Levine J, Rennke HG, Idelson BA. Profound persistent eosinophilia in a patient with spontaneous renal atheroembolic disease. Am J Nephrol 1992; 12:377. Hochreutener H, Wüthrich B, Huwyler T, et al. Variant of hyper-IgE syndrome: the differentiation from atopic dermatitis is important because of treatment and prognosis. Dermatologica 1991; 182:7. Schandené L, Ferster A, Mascart-Lemone F, et al. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 1993; 23:56.

Hochreutener H, Wüthrich B, Huwyler T, et al. Variant of hyper-IgE syndrome: the differentiation from atopic dermatitis is important because of treatment and prognosis. Dermatologica 1991; 182:7. Schandené L, Ferster A, Mascart-Lemone F, et al. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 1993; 23:56. Fitzmaurice RJ, Gardner DL. Thymoma with bone marrow eosinophilia. J R Soc Med 1990; 83:270. Topic 5691 Version 7.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1005-118.97.94.19-D760560F04-S244013.14]